Novartis Investigative Site

Haine-Saint-Paul 7100

0 studies enrolling now · 6 studies all time

What they study most

Acute Lymphoblastic Leukemia (Philadelphia Chromosome Positive), Carcinoma, Renal Cell, Chronic Myelogenous Leukemia, Hypereosinophilic Syndrome, Islet Cell Tumor, Leukaemia, Lymphocytic, Chronic, Neoplasms, Breast, Systemic Mastocytosis

Studies at this site

• ALTTO (Adjuvant Lapatinib And/Or Trastuzumab Treatment Optimisation) Study; BIG 2-06/N063D — Completed
• A Study of Oral AMN107 in Adults With Chronic Myelogenous Leukemia (CML) or Other Hematologic Malignancies — Completed
• Observational Study of Real World Effectiveness Data and Safety in Patients Receiving Pazopanib With Advanced or Metastatic Renal Cell Carcinoma — Completed
• Ofatumumab + Chlorambucil vs Chlorambucil Monotherapy in Previously Untreated Patients With Chronic Lymphocytic Leukemia — Stopped early
• Efficacy of Everolimus Alone or in Combination With Pasireotide LAR in Advanced PNET — Stopped early
• EAP (Expanded Access Protocol) Of Lapatinib Combined With Capecitabine In Metastatic Breast Cancer — APPROVED_FOR_MARKETING